Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Dual activation of the TLR7 and TLR8 pathways leads to the production of type I interferon and proinflammatory cytokines, resulting in efficient antigen presentation by dendritic cells to promote T-cell priming and antitumor immunity. We developed a novel series of TLR7/8 dual agonists with varying ratios of TLR7 and TLR8 activity for use as payloads for an antibody-drug conjugate approach. The agonist-induced production of several cytokines in human whole blood confirmed their functional activity. Structure-activity relationship studies guided by structure-based drug design are described.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11726388PMC
http://dx.doi.org/10.1021/acsmedchemlett.4c00463DOI Listing

Publication Analysis

Top Keywords

conjugate approach
8
tlr7 tlr8
8
structure-based design
4
design novel
4
novel tlr7/8
4
tlr7/8 agonist
4
agonist payloads
4
payloads enabling
4
enabling immunomodulatory
4
immunomodulatory conjugate
4

Similar Publications

Brain-computer interfaces (BCIs) enable direct communication between the brain and computers. However, their long-term functionality remains limited due to signal degradation caused by acute insertion trauma, chronic foreign body reaction (FBR), and biofouling at the device-tissue interface. To address these challenges, we introduce a multifunctional surface modification strategy called targeting-specific interaction and blocking nonspecific adhesion (TAB) coating for flexible fiber, achieving a synergistic integration of mechanical compliance and biochemical stability.

View Article and Find Full Text PDF

Phosphole-based fluorophores are attractive dyes for bioimaging due to their relatively compact molecular structures, strong fluorescence up to the near-infrared region with large Stokes shifts, and remarkable resistance to photobleaching. Therefore, the development of efficient and chemoselective coupling methods for functionalizing phospholes is of significant interest for biomolecular labeling. Herein, we describe the synthesis of novel P-aminophospholes and their use for direct conjugation to cysteinyl peptides under mild conditions.

View Article and Find Full Text PDF

Developing the efficient C─H bond activation carboxylation processes for furoic acid (FA) represents a critical technological challenge in achieving atom-economical synthesis of 2,5-furandicarboxylic acid (FDCA). Despite notable advancements in this field, the inherent contradiction between the high reactivity of furan rings and the chemical inertness of C─H bonds poses substantial technical bottleneck for achieving controllable C─H carboxylation under mild conditions. Herein, we report a high lattice-distorted MnOx catalyst with surface trench-like structures, wherein the Mn-O-conjugated configurations and electron-rich Mn cooperatively drive FA dehydrogenation and carbon radical reduction, inducing the free radical evolution process (FA→carbon-centered FA radical→FA carbanion), then coupled with solvent-polarized CO to accelerate the carboxylation process.

View Article and Find Full Text PDF

A strategy for targeting tumor-associated hypoxia utilizes reductase enzyme-mediated cleavage to convert biologically inert prodrugs to their corresponding biologically active parent therapeutic agents selectively in areas of pronounced hypoxia. Small-molecule inhibitors of tubulin polymerization represent unique therapeutic agents for this approach, with the most promising functioning as both antiproliferative agents (cytotoxins) and as vascular disrupting agents (VDAs). VDAs selectively and effectively disrupt tumor-associated microvessels, which are typically fragile and chaotic in nature.

View Article and Find Full Text PDF

Self-enriching nanozyme with photothermal-cascade amplification for tumor microenvironment-responsive synergistic therapy and enhanced photoacoustic imaging.

Mater Today Bio

October 2025

Yunnan Key Laboratory of Breast Cancer Precision Medicine, Institute of Biomedical Engineering, Kunming Medical University, Kunming, 650500, Yunnan, China.

Achieving precise intratumoral accumulation and coordinated activation remains a major challenge in nanomedicine. Photothermal therapy (PTT) provides spatiotemporal control, yet its efficacy is hindered by heterogeneous distribution of PTT agents and limited synergy with other modalities. Here, we develop a dual-activation nanoplatform (IrO-P) that integrates exogenous photothermal stimulation with endogenous tumor microenvironment (TME)-responsive catalysis for synergistic chemodynamic therapy (CDT) and ferroptosis induction.

View Article and Find Full Text PDF